ESC 365 - Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study

ESC Professional Premium Access

Risks and benefits of antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease: a nationwide cohort study

Session: The thoracoabdominal aorta in the spotlight: aneurysms, dissections, and their prognosis

Topic: Pharmacotherapy

Speaker: Doctor C. Nicolajsen (Viborg, DK)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Chalotte Winther Nicolajsen

Viborg Hospital, Viborg (Denmark)

0 follower

4 more presentations in this session

Male-female differences in the natural history of ascending thoracic aortic aneurysms: insights from the dissexion study

Speaker: Mr M. Notenboom (Rotterdam, NL)

The aortic root in young adults

Speaker: Doctor N. Chatrath (Harefield, Uxbridge, GB)

Long-term clinical outcomes of EVAR within IFU compared to outside IFU

Speaker: Doctor J. Kim (Incheon, KR)

The impact of endovascular aneurysm repair for ruptured abdominal aortic aneurysms: a single center experience.

Speaker: Doctor Y. Kobayashi (Kyoto, JP)

Access the full session

The thoracoabdominal aorta in the spotlight: aneurysms, dissections, and their prognosis

Speakers: Doctor C. Nicolajsen, Mr M. Notenboom, Doctor N. Chatrath, Doctor J. Kim, Doctor Y. Kobayashi

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by